CDH17 and gastric cancer: Taken together, our results demonstrate that A1 and E8 nanobodies can efficiently bind to CDH17, and specifically recognize the CDH17-overexpressing GC cell lines, and internalization of E8 nanobody endows it with potential applications for GC imaging and targeted therapy.